Pricing Log in Create free account

Akebia Therapeutics, Inc. (AKBA) vs Cardiol Therapeutics Inc. (CRDL)

Akebia Therapeutics, Inc. and Cardiol Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Akebia Therapeutics, Inc. and Cardiol Therapeutics Inc. are of similar size ($117.9M and $111.8M). Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −22.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Akebia Therapeutics, Inc. leads on 8 and Cardiol Therapeutics Inc. on 5.

Valuation

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.60 n/m 2.08
P/B 5.84 6.16 1.79
Price to free cash flow 8.59 n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.05 n/m 2.87
Earnings yield (37.21%) (26.88%) (15.94%)
Free cash flow yield 11.64% (16.13%) 0.00%

Profitability

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
Gross margin 78.90% 0.00% 53.51%
Operating margin (15.74%) 0.00% 0.00%
Net margin (22.60%) 0.00% (2.45%)
Free cash flow margin 7.03% 0.00% 0.00%
Return on equity (143.83%) (171.13%) (0.80%)
Return on assets (12.62%) (124.40%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (12.38%) — 5.22%
EPS growth (last fiscal year) 93.94% 24.32% 42.91%
Revenue growth, 5-year CAGR (4.33%) — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
Debt to equity 2.47 0.00 0.04
Current ratio 1.36 5.55 2.41
Net debt to EBITDA (5.51) 0.62 1.01

Dividend

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKBA CRDL Drug Manufacturers Specialty & Generic median
Market cap 117.91m 111.79m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack